Manelimab (Anti-B7-H1 / PD-L1 / CD274)Manelimab (Anti-B7-H1 / PD-L1 / CD274)
Move your mouse over image or click to enlarge

Manelimab (Anti-B7-H1 / PD-L1 / CD274)

Manelimab (Anti-B7-H1 / PD-L1 / CD274) is a monoclonal antibody directed against the immunosuppressive ligand programmed cell death-1 ligand 1 (PD-L1; cluster of differentiation 274; CD274), with potential immune checkpoint inhibitory and antineoplastic activities. MW: 143.68 kD.
Cat# Size Price Qty Buy
A2780-1mg*25 1mg*25
£4,152.00
A2780-1mg*5 1mg*5
£1,384.00
A2780-1mg 1mg
£441.00

Additional Information

Property Value or Rating
Manufacturer Selleck Chemicals LLC
Manufacturer Cat# A2780

Related Documents